Captrust Financial Advisors Paratek Pharmaceuticals, Inc. Transaction History

Captrust Financial Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$1.73 - $3.09 $833 - $1,489	482 Added 31.88%	1,994 $4,000
Q1 2022 May 16, 2022	BUY	$2.94 - $4.77 $2,016 - $3,272	686 Added 83.05%	1,512 $4,000
Q1 2021 May 17, 2021	BUY	$6.14 - $8.31 $159 - $216	26 Added 3.25%	826 $6,000
Q2 2020 Aug 14, 2020	BUY	$2.97 - $5.22 $2,376 - $4,176	800 New	800 $4,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.